Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis

Gastroenterology

Volumn 105, Issue 5, 1993, Pages 1522-1528

  Czaja, Albert J ^a   Carpenter, Herschel A ^a   Manns, Michael P ^b  

^a MAYO CLINIC   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYTOCHROME P450 ISOENZYME; ENZYME ANTIBODY; LIVER ANTIGEN; MICROSOME ANTIBODY; MITOCHONDRION ANTIBODY; PREDNISONE; PYRUVATE DEHYDROGENASE; RECOMBINANT INTERFERON; SMOOTH MUSCLE ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; ENZYME SUBUNIT; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; CHRONIC DISEASE; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HEPATITIS; HUMAN; KETONE OXIDOREDUCTASES; LIVER; MALE; MIDDLE AGE; MITOCHONDRIA; MIXED FUNCTION OXYGENASES; MULTIENZYME COMPLEXES; PYRUVATE DEHYDROGENASE COMPLEX;

EID: 0027448940     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(93)90160-E     Document Type: Article

References (33)

1. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology
2. Natural history, clinical features, and treatment of autoimmune hepatitis
3. Autoimmune chronic active hepatitis: a specific entity? The negative argument
4. Cytoplasmic autoantigens in autoimmune hepatitis: molecular analysis and clinical relevance
5. Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis
6. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen
7. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase
8. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis
9. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis
10. Detection of antimitochondrial antibodies: characterization by enzyme immunoassay and immunoblotting
11. Detection of anti-pyruvate dehydrogenase complex antibody in primary biliary cirrhosis by an enzyme-linked immunosorbent assay
12. Antibodies against mitochondrial dehydrogenase complexes in primary biliary cirrhosis
13. Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosis
14. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of “autoimmune” hepatitis
15. Type 2 autoimmune hepatitis and hepatitis C virus infection
16. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders
17. Anti-GOR and hepatitis C virus in autoimmune liver diseases
18. Subdivisions of idiopathic autoimmune chronic active hepatitis
19. Frequency and signifcance of antibody to hepatitis C virus in severe corticosteroidtreated cryptogenic chronic active hepatitis
20. Duration and specificity of antibodies to hepatitis C virus in chronic active hepatitis
21. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis
22. Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis
23. Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis
24. Hepatitis C virus infection in patients with nonalcoholic chronic liver disease
25. Frequency of antibody to hepatitis C virus in asymptomatic HBsAg-negative chronic active hepatitis
26. Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission
27. Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis
28. The nature and prognosis of severe cryptogenic chronic active hepatitis
29. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex
30. Frequency of IgG and IgM autoantibodies to the four specific M2 mitochondrial autoantigens in primary biliary cirrhosis
31. Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression
32. The target antigen of liver kidney microsomal antibody is different in type II autoimmune chronic active hepatitis and chronic hepatitis C virus infection (abstr)